BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 30317567)

  • 1. Lipid metabolism-related long noncoding RNA RP11-817I4.1 promotes fatty acid synthesis and tumor progression in hepatocellular carcinoma.
    Wang RY; Yang JL; Xu N; Xu J; Yang SH; Liang DM; Li JZ; Zhu H
    World J Gastroenterol; 2024 Feb; 30(8):919-942. PubMed ID: 38516243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compound K Induces Endoplasmic Reticulum Stress and Apoptosis in Human Liver Cancer Cells by Regulating STAT3.
    Zhang X; Zhang S; Sun Q; Jiao W; Yan Y; Zhang X
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29921768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DJ-1 promotes development of DEN-induced hepatocellular carcinoma and proliferation of liver cancer cells.
    Qiu B; Wang J; Yu Y; Zhen C; Gu J; Liu W; Wen Y; Chen L; Gao Y; Xia Q; Kong X
    Oncotarget; 2017 Jan; 8(5):8499-8511. PubMed ID: 28036277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5'-tiRNA-Gln inhibits hepatocellular carcinoma progression by repressing translation through the interaction with eukaryotic initiation factor 4A-I.
    Wu C; Liu D; Zhang L; Wang J; Ding Y; Sun Z; Wang W
    Front Med; 2023 Jun; 17(3):476-492. PubMed ID: 36973570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erratum: Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3.
    Hepatology; 2024 Jun; 79(6):E171-E172. PubMed ID: 38758105
    [No Abstract]   [Full Text] [Related]  

  • 6. LINC00707 promotes hepatocellular carcinoma progression through activating ERK/JNK/AKT pathway signaling pathway.
    Wang J; Luo Z; Yao T; Li W; Pu J
    J Cell Physiol; 2019 May; 234(5):6908-6916. PubMed ID: 30317590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of P53 in Myocardial Ischemia-Reperfusion Injury.
    Zhu XZ; Qiu Z; Lei SQ; Leng Y; Li WY; Xia ZY
    Cardiovasc Drugs Ther; 2023 Jun; ():. PubMed ID: 37389674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciphering STAT3 signaling potential in hepatocellular carcinoma: tumorigenesis, treatment resistance, and pharmacological significance.
    Hashemi M; Sabouni E; Rahmanian P; Entezari M; Mojtabavi M; Raei B; Zandieh MA; Behroozaghdam M; Mirzaei S; Hushmandi K; Nabavi N; Salimimoghadam S; Ren J; Rashidi M; Raesi R; Taheriazam A; Alexiou A; Papadakis M; Tan SC
    Cell Mol Biol Lett; 2023 Apr; 28(1):33. PubMed ID: 37085753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Has_circ_0008583 modulates hepatocellular carcinoma progression through the miR-1301-3p/METTL3 pathway.
    Wang F; Xie Z; Zhang N; Ding H; Xiong K; Guo L; Huang H; Wen Z
    Bioengineered; 2022 Jan; 13(1):1185-1197. PubMed ID: 35258395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA-378a-3p regulates the progression of hepatocellular carcinoma by regulating PD-L1 and STAT3.
    Li Y; Zhou T; Cheng X; Li D; Zhao M; Zheng WV
    Bioengineered; 2022 Mar; 13(3):4730-4743. PubMed ID: 35184646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant Expression of miR-1301 in Human Cancer.
    Zhong C; Dong Y; Zhang Q; Yuan C; Duan S
    Front Oncol; 2021; 11():789626. PubMed ID: 35070996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of five miRNAs in papillary thyroid carcinomas.
    Qiao DH; He XM; Deng X; Ji YC; Yang H; Cheng L; Zhou XY
    J Clin Lab Anal; 2021 Sep; 35(9):e23907. PubMed ID: 34268792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Long Non-Coding RNAs in the Pathogenesis of Hepatocellular Carcinoma.
    Ghafouri-Fard S; Gholipour M; Hussen BM; Taheri M
    Front Oncol; 2021; 11():649107. PubMed ID: 33968749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINC01433 targets miR-506-3p to promote the biological progress of nasopharyngeal carcinoma cells.
    Zhou M; Dong Z; Hu S; Xiao M
    Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3363-3374. PubMed ID: 33479848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA FAM83A-AS1 facilitates hepatocellular carcinoma progression by binding with NOP58 to enhance the mRNA stability of FAM83A.
    He J; Yu J
    Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31696213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Feedback Loop Regulation Of LINC01433 And YAP Promotes Malignant Behavior In Gastric Cancer Cells.
    Zhang C; Qian H; Liu K; Zhao W; Wang L
    Onco Targets Ther; 2019; 12():7949-7962. PubMed ID: 31632054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA SLCO4A1-AS1 promotes growth and invasion of bladder cancer through sponging miR-335-5p to upregulate OCT4.
    Yang Y; Wang F; Huang H; Zhang Y; Xie H; Men T
    Onco Targets Ther; 2019; 12():1351-1358. PubMed ID: 30863101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LINC01433 promotes hepatocellular carcinoma progression via modulating the miR-1301/STAT3 axis.
    Huang H; Bu YZ; Zhang XY; Liu J; Zhu LY; Fang Y
    J Cell Physiol; 2019 May; 234(5):6116-6124. PubMed ID: 30317567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long noncoding RNA NEAT1 contributes to hepatocellular carcinoma development by sponging miR-485 and enhancing the expression of the STAT3.
    Zhang XN; Zhou J; Lu XJ
    J Cell Physiol; 2018 Sep; 233(9):6733-6741. PubMed ID: 29219178
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.